Neomorph’s $1.6 Billion Collaboration with AbbVie

Leila Ahmed North America Legal Chronicle
Tagged:

Ropes & Gray advised Neomorph on the deal.Biotechnology company Neomorph announced a collaboration and option-to-license agreement with AbbVie (NYSE: ABBV) to develop novel molecular glue degraders…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here